National Drug Strategy
National Drug Strategy

National Illicit Drug Strategy Publications

Print page  Decrease text size  Increase text size


General Illicit Drug Resources

National Heroin Overdose Strategy
The Strategy identifies priorities for action aimed at preventing and managing overdose. The Strategy comprises 2 documents:
  • the Strategy
  • a foldout summary
Date Published: 2001
ISBN: 0 642 50335 4
Author: Commonwealth Department of Health and Aged Care
ID13
National Action Plan on Illicit Drugs 2001 to 2002-03
The National Action Plan on Illicit Drugs is comprised of three documents:
  • the Action Plan
  • a Foldout Summary
  • a Background paper
Date Published: 2001
ISBN: 0 642 73563 8
Author: Siggins Miller Consultants with the National Expert Advisory Committee on Illicit Drugs
ID32 Folder
ID48 Book
ID49 Foldout Brochure
National Cannabis Strategy 2006-2009
Date Published: 2006
ISBN: 1 74186 002 4
Author: Commonwealth Department of Health and Ageing
ID73
Top of page

Psychostimulants

National Amphetamine-Type Stimulant Strategy 2008-2011
Date Published: 2008
Authors: National Drug Research Institute (NDRI); Australian Institute of Criminology (AIC)
NDSU77
Illicit Psychostimulant Use in Australia
Date Published: 1993
ISBN: 0 644 28629 6
Author: Edited by Dave Burrows, Bruce Flaherty and Michael MacAvoy
ID28
Psychostimulants - Management of Acute Behavioural Disturbances. Guidelines for Police Services
Date Published: 2004
ISBN: 0 642 82523 8
Author: Linda Jenner, Amanda Baker, Ian Whyte and Vaughan Carr
ID51
Management of Patients with Psychostimulant Use Problems. Guidelines for General Practitioners
Date Originally Published: 2004
Revised and Republished: 2007
ISBN: 1 74186 471 2
Online ISBN: 1 74186 472 0
Author: Linda Jenner, Amanda Baker, Ian Whyte and Vaughan Carr
ID53
Management of Patients with Psychostimulant Toxicity: Guidelines for Emergency Departments
Date Published: 2006
ISBN: 1 741 86059 8
Author: Linda Jenner, David Spain, Ian Whyte, Amanda Baker, Vaughan Carr and Julia Crilly
ID50
Management of Patients with Psychostimulant Toxicity: Guidelines for Ambulance Services
Date Published: 2006
ISBN: 1 741 86057 1
Author: Linda Jenner, David Spain, Ian Whyte, Amanda Baker, Vaughan Carr and Julia Crilly
ID75
Top of page

Treatment Guidelines for Opioid Dependance

Learning objectives for methadone prescribers
Date Published: 1997
ISBN: 0 644 47649 4
Author: S. Allsop, J. Bell, R. Brough, P. Dwyer, C. Edmonds, N. Lintzeris and V. Mohindra
ID07
A brief cognitive behavioural intervention for regular amphetamine users - A treatment guide
Date Published: 2003
ISBN: 0 642 823863 3
Author: Baker, A., Kay-Lambkin, F., Lee, N.K., Claire, M. & Jenner, L. (2003)
ID02
National Pharmacotherapy Policy for People Dependent on Opioids
Date Originally Published: 2004
Date Revised: January 2007
ISBN: 1 74186 274 4
Online ISBN: 1 74186 275 2
Author: Intergovernmental Committee on Drugs
ID40
Treatment options for Heroin and other Opioid Dependence guidelines - A Guide for Frontline Workers
Date Published: October 2004
ISBN: 0 642 82487 8
Author: Susannah O'Brien
ID41
Treatment Options for Heroin and other Opioid Dependence - A Guide for Users
Date Published: October 2004
ISBN: 0 642 82488 6
Author: Susannah O'Brien, National Drug and Alcohol Research Centre
ID42
Treatment options for Heroin and other Opioid Dependence - A Guide for Families and Carers
Date Published: October 2004
ISBN: 0 642 82486 X
Author: Susannah O'Brien, National Drug and Alcohol Research Centre
ID43
National Learning Objectives and Assessment Procedures for the Pharmacological Management of Opioid Dependence
Date Published: 2004
ISBN: 0 642 82192 5
Author: Robert Ali, Steve Allsop, James Bell, Roger Brough, Angela Corry, Liz Ernst, Liz Farmer, Tony Gill, Sue Henry-Edwards, Nick Lintzeris, Moira Sim and Michael Tedeschi
ID44
National Buprenorphine Policy
Date Published: 2001
ISBN 0 642 73575 7
Author: Ali R, Biggs L, Dorlego B, Gill T, Larkins K, Moyle K, Murray T, Perrin J, Quigley A, Rysavy P, Sunjic S, Wilson C, Richards I.
ID10
National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Opioid Dependence
Date Published: 2001
Date Modified: 2006
ISBN 0 642 73573 5
Author: Lintzeris N, Clark N, Winstock A, Dunlop A, Muhleisen P, Gowing L, Ali R, Bell J, Quigley A, Mattick RP, Monheit B, and White J.
ID12
National Clinical Guidelines for the Use of Buprenorphine in the Treatment of Opioid Dependence – Abbreviated Version
Date Published: 2006
Author: Lintzeris N, Clark N, Winstock A, Dunlop A, Muhleisen P, Gowing L, Ali R, Bell J, Quigley A, Mattick RP, Monheit B, and White J
Top of page

Performance and Image Enhancing Drugs (PIEDs)

Performance and Image Enhancing Drugs - Clenbuterol Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - Creatine Monohydrate Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - Erythropoietin (EPO) Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - Human Chorionic Gonadotrophin (hCG) Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - What is Insulin-like Growth Factor (IGF-1) Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - Insulin Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P
Performance and Image Enhancing Drugs - Human Growth Hormone (hgH) Fact Sheet
Date Published: November 2005
Author: Larance, B. & Dillon, P

Page currency, Latest update: 17 September, 2008

If you are having difficulty downloading the PDF document(s) please email phd.webmaster@health.gov.au and we will arrange for an alternative format or a copy to be sent to you.

Get Acrobat ReaderTo view PDF (Portable Document Format) documents, you will need to have a PDF reader installed on your computer. The Adobe Acrobat Reader is available free of charge from Adobe's website.